Frontier’s Precision Pipeline

Frontier Medicines scientist in a lab

Precision-based Pipeline

Building a pipeline of precision medicines initially focused on oncology


Frontier Medicines scientist pipetting

Dual KRASG12C Inhibitor

Advancing lead program that uniquely inhibits both active and inactive forms of this KRAS mutation